Nouvo aplikasyon EMA OKs Biomarin pou apwouve Roctavian

Nouvo aplikasyon EMA OKs Biomarin pou apwouve Roctavian

Emofili Nouvèl Jodi a

Imaj

Please enable the javascript to submit this form

Sipòte pa sibvansyon edikasyon bay Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, ak uniQure, Inc.

Esansyèl SSL